Literature DB >> 21554030

Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis.

Nazem Atassi1, Merit E Cudkowicz, David A Schoenfeld.   

Abstract

A few studies suggest that non-invasive ventilation (1) and gastric tube (G-tube) may have a positive impact on survival but the effect on functional decline is unclear. Confounding by indication may have produced biased estimates of the benefit seen in some of these retrospective studies. The objective of this study was to evaluate the effects of G-tube and NIV on survival and functional decline using advanced statistical models that adjust for confounding by indications. A database of 331 subjects enrolled in previous clinical trials in ALS was available for analysis. Marginal structural models (MSM) were used to compare the mortality hazards and ALSFRS-R slopes between treatment and non-treatment groups, after adjusting for confounding by indication. Results showed that the placement of a G-tube was associated with an additional 1.42 units/month decline in the ALSFRS-R slope (p < 0.0001) and increased mortality hazard of 0.28 (p = 0.02). The use of NIV had no significant effect on ALSFRS-R decline or mortality. In conclusion, marginal structural models can be used to adjust for confounding by indication in retrospective ALS studies. G-tube placement could be followed by a faster rate of functional decline and increased mortality. Our results may suffer from some of the limitations of retrospective analyses.

Entities:  

Mesh:

Year:  2011        PMID: 21554030      PMCID: PMC3138079          DOI: 10.3109/17482968.2011.577786

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  22 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Authors:  Miguel A Hernán; Babette A Brumback; James M Robins
Journal:  Stat Med       Date:  2002-06-30       Impact factor: 2.373

3.  Ceftriaxone as effective therapy in refractory Lyme disease.

Authors:  R J Dattwyler; J J Halperin; H Pass; B J Luft
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

Review 5.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

6.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

7.  Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction.

Authors:  H Mitsumoto; M Davidson; D Moore; N Gad; M Brandis; S Ringel; J Rosenfeld; J M Shefner; M J Strong; R Sufit; F A Anderson
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2003-09

8.  Noninvasive ventilation in ALS: indications and effect on quality of life.

Authors:  S C Bourke; R E Bullock; T L Williams; P J Shaw; G J Gibson
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

9.  Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function.

Authors:  L M Mathus-Vliegen; L S Louwerse; M P Merkus; G N Tytgat; J M Vianney de Jong
Journal:  Gastrointest Endosc       Date:  1994 Jul-Aug       Impact factor: 9.427

Review 10.  Review of respiratory care of the patient with amyotrophic lateral sclerosis.

Authors:  M S Sherman; H L Paz
Journal:  Respiration       Date:  1994       Impact factor: 3.580

View more
  6 in total

1.  Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Authors:  Philippe Corcia; Caroline Ingre; Helene Blasco; Rayomand Press; Julien Praline; Catherine Antar; Charlotte Veyrat-Durebex; Yves-Olivier Guettard; William Camu; Peter M Andersen; Patrick Vourc'h; Christian R Andres
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 2.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

Review 3.  What causes amyotrophic lateral sclerosis?

Authors:  Sarah Martin; Ahmad Al Khleifat; Ammar Al-Chalabi
Journal:  F1000Res       Date:  2017-03-28

Review 4.  Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives.

Authors:  Osama A Khairoalsindi; Ahmad R Abuzinadah
Journal:  Neurol Res Int       Date:  2018-08-12

5.  A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Authors:  Leila Bond; Paulamy Ganguly; Nishad Khamankar; Nolan Mallet; Gloria Bowen; Braden Green; Cassie S Mitchell
Journal:  Brain Sci       Date:  2019-09-04

6.  Causal inference methods to study gastric tube use in amyotrophic lateral sclerosis.

Authors:  Erin McDonnell; David Schoenfeld; Sabrina Paganoni; Nazem Atassi
Journal:  Neurology       Date:  2017-09-01       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.